Shilpa Medicare Limited recalls PEMRYDI RTU (pemetrexed injection) and…
Shilpa Medicare Limited recalls PEMRYDI RTU (pemetrexed injection) and 1 more
- Published
- 26 Aug 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1
PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2461-1
- Brand / company
- Shilpa Medicare Limited
- Codes / lots
- Lot: P400172; Lot PA00050A, Exp 09/30/2027 | Lot: P400157, Exp 08/31/2026; Lot PA00047A, Exp 09/30/2027
- Distribution
- Nationwide in the USA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 26 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.